Key points are not available for this paper at this time.
Cytomegalovirus (CMV) is a ubiquitous herpes virus that infects the majority of humans (1). The seroprevalence rates of CMV ranges from 30–97% (2,3). Primary infection manifests as an asymptomatic or self-limited febrile illness in immunocompetent individuals, after which CMV establishes life-long latency in various cells (2,3), which serve as reservoirs for reactivation and as carriers of infection to susceptible individuals (4,5).
Razonable et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: